IBM (IBM) is trading up at $221.65 (+0.16%) on NYSE/NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Information Technology sector.
Current price targets from 7 firms average $239, median $245, ranging from $191 to $270 — the average is 8% above the current $222. Each is tracked to its date and scored the same way a member's call is.
Targets published by research firms, extracted from the news, checked against independent reporting, and linked to their source. Where a firm did not state a horizon the target is tracked as 12 months, the industry convention; the rows where the firm set its own horizon are marked. Reported here as facts about what was published — not recommendations from Dalsna Finance, and no firm listed is affiliated with this site.
| FY2016Dec 2016 | FY2017Dec 2017 | FY2018Dec 2018 | FY2019Dec 2019 | FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $79.9B | $79.1B | $79.6B | $57.7B | $55.2B | $57.4B | $60.5B | $61.9B | $62.8B | $67.5B |
| Growth (year over year) | −2.2% | −1.0% | +0.6% | −27.5% | −4.4% | +3.9% | +5.5% | +2.2% | +1.4% | +7.6% |
| Gross profit | $38.5B | $36.9B | $36.9B | $31.5B | $30.9B | $31.5B | $32.7B | $34.3B | $35.6B | $39.3B |
| Gross margin | 48.2% | 46.7% | 46.4% | 54.6% | 55.9% | 54.9% | 54.0% | 55.4% | 56.7% | 58.2% |
| Net income | $11.9B | $5.75B | $8.73B | $9.43B | $5.59B | $5.74B | $1.64B | $7.50B | $6.02B | $10.6B |
| Net margin | 14.9% | 7.3% | 11.0% | 16.3% | 10.1% | 10.0% | 2.7% | 12.1% | 9.6% | 15.7% |
| EPS (diluted) | $12.38 | $6.14 | $9.52 | $10.56 | $6.23 | $6.35 | $1.80 | $8.14 | $6.43 | $11.17 |
| Balance sheet | ||||||||||
| Cash and equivalents | $7.83B | $12.0B | $11.4B | $8.17B | $13.2B | $6.65B | $7.89B | $13.1B | $13.9B | $13.6B |
| Total assets | $117.5B | $125.4B | $123.4B | $152.2B | $156.0B | $132.0B | $127.2B | $135.2B | $137.2B | $151.9B |
| Total liabilities | $99.1B | $107.6B | $106.5B | $131.2B | $135.2B | $113.0B | $105.2B | $112.6B | $109.8B | $119.1B |
| Long-term debt | $34.7B | $39.8B | $35.6B | $54.1B | $54.2B | $44.9B | $46.2B | $50.1B | $49.9B | $54.8B |
| Shareholders' equity | $18.2B | $17.6B | $16.8B | $20.8B | $20.6B | $18.9B | $21.9B | $22.5B | $27.3B | $32.6B |
| Cash flow | ||||||||||
| Operating cash flow | $17.1B | $16.7B | $15.2B | $14.8B | $18.2B | $12.8B | $10.4B | $13.9B | $13.4B | $13.2B |
| Capital expenditure | $3.57B | $3.23B | $3.40B | $2.29B | $2.62B | $2.06B | $1.35B | $1.25B | $1.05B | $1.09B |
| Free cash flow | $13.5B | $13.5B | $11.9B | $12.5B | $15.6B | $10.7B | $9.09B | $12.7B | $12.4B | $12.1B |
| Dividends paid | $5.26B | $5.51B | $5.67B | $5.71B | $5.80B | $5.87B | $5.95B | $6.04B | $6.15B | $6.25B |
| Share buybacks | $3.50B | $4.34B | $4.44B | $1.36B | — | — | — | — | — | — |
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $15.0B | $17.6B | $14.5B | $17.0B | $16.3B | $19.7B | $15.9B | $17.2B |
| Growth (year over year) | +1.5% | +1.0% | +0.5% | +7.7% | +9.1% | +12.2% | +9.5% | +1.1% |
| Gross profit | $8.42B | $10.4B | $8.03B | $9.98B | $9.36B | $11.9B | $8.95B | $9.91B |
| Gross margin | 56.3% | 59.5% | 55.2% | 58.8% | 57.3% | 60.6% | 56.2% | 57.7% |
| Net income | −$330.0M | $2.91B | $1.05B | $2.19B | $1.74B | $5.60B | $1.22B | $2.17B |
| Net margin | −2.2% | 16.6% | 7.3% | 12.9% | 10.7% | 28.4% | 7.6% | 12.6% |
| EPS (diluted) | −$0.36 | $3.11 | $1.12 | $2.31 | $1.84 | $5.90 | $1.28 | $2.27 |
| Balance sheet | ||||||||
| Cash and equivalents | $13.2B | $13.9B | $11.0B | $11.9B | $11.6B | $13.6B | $10.8B | $7.17B |
| Total assets | $134.3B | $137.2B | $145.7B | $148.6B | $146.3B | $151.9B | $156.2B | $152.1B |
| Total liabilities | $109.8B | $109.8B | $118.7B | $121.0B | $118.3B | $119.1B | $123.2B | $117.6B |
| Long-term debt | $53.0B | $49.9B | $56.4B | $55.2B | $55.2B | $54.8B | $57.7B | $56.2B |
| Shareholders' equity | $24.4B | $27.3B | $26.9B | $27.5B | $27.9B | $32.6B | $33.0B | $34.5B |
| Cash flow | ||||||||
| Operating cash flow | $2.88B | $4.33B | $4.37B | $1.70B | $3.08B | $4.04B | $5.17B | $2.60B |
| Capital expenditure | $286.0M | $303.0M | $244.0M | $210.0M | $255.0M | $382.0M | $232.0M | $229.0M |
| Free cash flow | $2.60B | $4.03B | $4.13B | $1.49B | $2.83B | $3.66B | $4.94B | $2.37B |
| Dividends paid | $1.54B | $1.55B | $1.55B | $1.56B | $1.57B | $1.57B | $1.58B | $1.59B |
From IBM's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
International Business Machines Corporation, doing business as IBM, is an American multinational technology company headquartered in Armonk, New York, and present in over 175 countries. It is a publicly traded company and one of the 30 companies in the Dow Jones Industrial Average. IBM is the largest industrial research organization in the world, with 19 research facilities across a dozen countries; for 29 consecutive years, from 1993 to 2021, it held the record for most annual U.S. patents generated by a business.